Skip to main content
. Author manuscript; available in PMC: 2016 Feb 1.
Published in final edited form as: Leuk Lymphoma. 2014 Jun 27;56(2):434–439. doi: 10.3109/10428194.2014.916803

Table 4.

Complementary and Alternative Medicine (CAM) use by NHL Type, Molecular Epidemiology Resource

Total
(N=719)
DLBCL
(N=207)
FL
(N=245)
MCL
(N=48)
MZL
(N=97)
Other NHL
(N=77)
T-cell
(N=45)
P value
Vitamins
  Any vitamin use 557 (78%) 157 (76%) 190 (78%) 40 (83%) 76 (78%) 59 (77%) 35 (78%) .93
Herbal supplements
  Any herbal supplement use 320 (45%) 84 (41%) 118 (48%) 18 (38%) 49 (51%) 33 (43%) 18 (40%) .36
  Any herbal supplement use for cancer 116 (16%) 28 (14%) 42 (17%) 9 (19%) 17 (18%) 14 (18%) 6 (13%) .83
  Any herbal supplement use for other health issues 284 (40%) 76 (37%) 105 (43%) 15 (31%) 45 (46%) 28 (36%) 15 (33%) .29
Therapies and techniques
  Any use 389 (54%) 112 (54%) 132 (54%) 28 (58%) 54 (56%) 37 (48%) 26 (58%) .87
  Any use for cancer 132 (18%) 40 (19%) 42 (17%) 15 (31%) 11 (11%) 12 (16%) 12 (27%) .04
  Any use for other health issues 367 (51%) 104 (50%) 127 (52%) 24 (50%) 53 (55%) 36 (47%) 23 (51%) .94
Any CAM use 636 (89%) 178 (86%) 223 (91%) 44 (92%) 84 (87%) 67 (87%) 40 (89%) .83

Abbreviations: DLBCL, Diffuse large B-cell lymphoma; FL, Follicular lymphoma; MCL, Mantle cell lymphoma; MZL, Marginal zone lymphoma; T-Cell, T-cell lymphoma; NHL, Non-Hodgkin lymphoma